⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL184454 | 0.83 | — | — | |
| SCHEMBL2033144 | 0.74 | — | — | |
| SCHEMBL37950 | 0.70 | MEN1 (0.35) | — | |
| Hydrochloric Acid SCHEMBL4647777 | 0.68 | APAF1 (0.33) | — | |
| Bromide SCHEMBL28523892 | 0.68 | APAF1 (0.33) | — | |
| SCHEMBL640436 | 0.68 | APAF1 (0.33) | — | |
| Water SCHEMBL11357123 | 0.68 | APAF1 (0.33) | — | |
| SCHEMBL31241401 | 0.68 | APAF1 (0.33) | — | |
| SCHEMBL3150791 | 0.65 | — | — | |
| SCHEMBL2145086 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3638 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024120471-A1 | COMPOUNDS TARGETING MUTANT OF P53 | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2024-06-13 | — | — | WO | claimed |
| CN-117510350-A | Stilbene And-1 protein degradation agent, preparation method And application thereof | 中国医学科学院放射医学研究所 | 2024-02-06 | — | — | CN | claimed |
| CN-117327065-A | Carbazole derivatives as dopamine D2/3 receptor modulators | 北京大学 | 2024-01-02 | — | — | CN | claimed |
| WO-2023213965-A1 | INHIBITORS OF CDK8 AND CDK19 | UNIVERSITY OF DUNDEE (GB) | 2023-11-09 | — | — | WO | claimed |
| CN-116693533-A | Five-membered heteroaromatic ring type gin-MLL interaction inhibitor, preparation method and medical application thereof | 成都硕德药业有限公司 | 2023-09-05 | — | — | CN | claimed |
| US-20230143552-A1 | DOPAMINE D2 RECEPTOR LIGANDS | THE BROAD INSTITUTE, INC. (US) | 2023-05-11 | — | — | US | claimed |
| WO-2023064195-A1 | CGRP ANTAGONISTS FOR TREATING TRIGEMINAL NEURALGIA | PFIZER IRELAND PHARMACEUTICALS (IE) | 2023-04-20 | — | — | WO | claimed |
| US-20230116602-A1 | MCL1 INHIBITORS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-04-13 | — | — | US | claimed |
| WO-2023034466-A1 | CGRP ANTAGONISTS FOR TREATING PSORIASIS | PFIZER IRELAND PHARMACEUTICALS (IE) | 2023-03-09 | — | — | WO | claimed |
| WO-2023034467-A2 | CGRP ANTAGONISTS FOR TREATING SKIN CONDITIONS | PFIZER IRELAND PHARMACEUTICALS (IE) | 2023-03-09 | — | — | WO | claimed |
| US-4314938-A | Iminoisoindolinone pigments containing phenylazoacetoacetyl-aminophenylene groups | CIBA-GEIGY CORPORATION (US) | 1982-02-09 | — | — | US | claimed |
| US-4294966-A | SALT FORMATION | CIBA-GEIGY CORPORATION (US) | 1981-10-13 | — | — | US | claimed |
| US-4231799-A | MONOAZO DYES, MULTILAYER, CHARGE TRANSPORTING COMPOUND | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-11-04 | — | — | US | claimed |
| EP-0007605-A1 | A process for inverting the configuration in optically active compounds and optically active intermediate compounds and their salts required therefor | CIBA-GEIGY AG (CH) | 1980-02-06 | — | — | EP | claimed |
| US-4166117-A | HYPOTENSIVES | SCIENCE UNION ET CIE (FR) | 1979-08-28 | — | — | US | claimed |
| US-4131733-A | PIGMENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-12-26 | — | — | US | claimed |
| US-4074053-A | Aldehydes of 2-hydroxy-naphthalene-3-carboxylic acid arylides | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-02-14 | — | — | US | claimed |
| US-4042591-A | PIGMENTS, DISPERSE DYES | SANDOZ LTD. (CH) | 1977-08-16 | — | — | US | claimed |
| US-4042577-A | POLYESTERS, POLYAMIDES, CELLULOSE ACETATES | SANDOZ LTD. (CH) | 1977-08-16 | — | — | US | claimed |
| US-4041036-A | NAPHTHO(1',2':5,6)-PYRANO(2,3-D)PYRIMIDINE DYES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-08-09 | — | — | US | claimed |